Zydus Lifesciences Ltd. (ZYDUSLIFE): Zydus Lifesciences Share Price Near 52-Week High After 0.90% Rise

Zydus Lifesciences Share Price is trading at Rs 1,222.95, up 0.90% from the previous close, and remains close to its 52-week high with a market capitalisation of Rs 1,19,899.96 crore. The latest move keeps Zydus Lifesciences Share Price Today in focus for Stock Market Today watchers, not because of an unverified trigger, but because the price is sitting near a yearly high while the company continues to show a sizeable valuation and profitability profile. Univest data also shows the stock’s current pricing against its recent range, which makes Zydus Lifesciences Stock News relevant for readers tracking Indian Stock Market updates, Share Market Today action and 52 Week High Stocks. The move is noteworthy, but the latest figures confirm the price event rather than a specific company-level cause.

Zydus Lifesciences Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,222.95
Previous Close	Rs 1,212
Today's Move	+Rs 10.95 (+0.9%)
Open	Rs 1,219.95
High	Rs 1,232
Low	Rs 1,208.3
Market Capitalisation	Rs 1,19,899.96 crore

Zydus Lifesciences Ltd. (ZYDUSLIFE) traded at Rs 1,222.95 versus the previous close of Rs 1,212, a rise of 0.9%. The stock opened at Rs 1,219.95, reached a high of Rs 1,232 and touched a low of Rs 1,208.3.

Zydus Lifesciences Share Price Today is trading at Rs 1,222.95 versus the previous close of Rs 1,212, a rise of Rs 10.95 or 0.90%. The stock opened at Rs 1,219.95 and moved between Rs 1,208.30 and Rs 1,232 during the session so far, leaving it just below the day’s high while still close to its 52-week high. Zydus Lifesciences Share Price Live therefore reflects a firm intraday position around the upper part of the day’s range, with no need to overstate the move beyond the price data itself. For readers following Zydus Lifesciences Share Price Update, the practical point is simple: the stock is trading near a one-year high and remains in the spotlight on NSE and BSE screens. That sets up the question of whether the move is supported by company fundamentals and sector context.

Why Zydus Lifesciences Ltd. (ZYDUSLIFE) May Be Moving Today

According to recent news reports, Zydus Lifesciences’ Ahmedabad SEZ II plant has completed a USFDA inspection with one observation, while no data-integrity issues were identified. That development may be linked to the firm tone in Zydus Lifesciences Stock News today, as it avoids major regulatory concerns that could affect production or exports. The update coincides with Zydus Lifesciences Share Price trading near its 52-week high, so Zydus Lifesciences News Today and Zydus Lifesciences Share News are both being watched closely. In Univest terms, the latest Zydus Lifesciences Company News adds a factual regulatory angle, but the price move itself still needs to be read alongside the wider market and sector context.

Zydus Lifesciences Ltd. (ZYDUSLIFE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,19,899.96 crore
P/E Ratio	26.79x
P/B Ratio	4.48x
ROE	19.69%
ROCE	21.39%
EPS	Rs 45.24
Book Value Per Share	Rs 270.31
Dividend Yield	0.08%

Zydus Lifesciences Ltd. (ZYDUSLIFE) fundamental metrics show P/E 26.79x, P/B 4.48x, ROE 19.69%, ROCE 21.39%. These figures provide context only and are not a buy or sell signal.

Zydus Lifesciences Ltd. has a market capitalisation of Rs 119899.96 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 26.79x, P/B at 4.48x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.69% and ROCE of 21.39%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 45.24, book value per share of Rs 270.31, dividend yield of 0.08%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.3x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	26.79x
Benchmark Median P/E	28.3x
Benchmark Average P/E	41.69x
Benchmark P/E Range	0x to 707.31x
Company P/B Ratio	4.48x
Benchmark Median P/B	2.83x
Company ROE	19.69%
Benchmark Median ROE	11.7%
Company ROCE	21.39%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 1,19,899.96 crore
Benchmark Median Market Cap	Rs 782.41 crore

Zydus Lifesciences Ltd. (ZYDUSLIFE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 26.79x, which is below the benchmark median of 28.3x, a difference of -5.34%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROE of 19.69%, which is above the benchmark median of 11.7%, a difference of +68.29%. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROCE of 21.39%, which is above the benchmark median of 13.46%, a difference of +58.92%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Cipla Ltd.	CIPLA	1,12,875.68	33.29	3.19	11.83	16
Laurus Labs Ltd.	LAURUSLABS	1,08,116.47	99.43	19.28	18.31	18.2
Mankind Pharma Ltd.	MANKIND	1,02,247.25	49.33	5.99	12.69	13.24
Dr. Reddy's Laboratories Ltd.	DRREDDY	1,00,395.34	31.67	2.67	11.69	13.75
Aurobindo Pharma Ltd.	AUROPHARMA	98,464.42	26.35	2.51	9.93	12.76

Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 26.79x compared with the displayed peer median of 33.29x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.69% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 21.39% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a market capitalisation of Rs 1,19,899.96 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Zydus Lifesciences

• Zydus Lifesciences Share Price is at Rs 1,222.95 and remains near its 52-week high.
• Zydus Lifesciences Share Price Today is 0.90% higher than the previous close of Rs 1,212.
• The stock’s market capitalisation is Rs 1,19,899.96 crore, which places it well above the industry median.
• P/E at 26.79 is below the same-industry median of 28.3 and below the industry average of 41.69.
• Recent news reports mention a USFDA inspection with one observation and no data-integrity issues.

About Zydus Lifesciences

Zydus Lifesciences Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Zydus Lifesciences Share Price reflects a business that is tracked on NSE and BSE as part of the Indian Stock Market’s pharma universe.Zydus Lifesciences Latest News, Zydus Lifesciences Market Cap and Zydus Lifesciences Stock News are therefore being followed together by readers who want both the price update and the company backdrop. Univest data places the company within a large same-industry peer group, which makes the stock useful for comparative analysis rather than isolated price watching.

Frequently Asked Questions

Why is Zydus Lifesciences Share Price in focus today?

Ans. Zydus Lifesciences Share Price is in focus because it is trading near its 52-week high at Rs 1,222.95, while also showing a 0.90% rise from the previous close.

What is the latest Zydus Lifesciences Share Price Today?

Ans. Zydus Lifesciences Share Price Today is Rs 1,222.95. The stock was up Rs 10.95 from the previous close of Rs 1,212 and traded between Rs 1,208.30 and Rs 1,232.

How close is Zydus Lifesciences Share Price to its yearly high?

Ans. Zydus Lifesciences Share Price is close to its 52-week high, with the current price at Rs 1,222.95. That makes the stock relevant for readers tracking one-year high levels on NSE and BSE.

How do Zydus Lifesciences fundamentals compare with peers?

Ans. Zydus Lifesciences has a P/E of 26.79, below the same-industry median of 28.3, and an ROE of 19.69%, above the industry median of 11.7%. Those numbers compare well with several peers.

Is Zydus Lifesciences Share Price expensive versus the sector?

Ans. Zydus Lifesciences Share Price trades on a P/E below the industry median and around the benchmark average on P/B. That gives the stock a valuation profile that is neither extreme nor cheap in isolation.

What does Zydus Lifesciences market cap tell investors?

Ans. Zydus Lifesciences Market Cap stands at Rs 1,19,899.96 crore, placing the company well above the industry median in the benchmark set. Market cap indicates size, not quality, but it helps compare scale.

Where can readers track Zydus Lifesciences Share Price Live?

Ans. Readers can track Zydus Lifesciences Share Price Live on Univest, where the stock page brings together price, valuation, financial results, market capitalisation and peer comparison in one place for quick monitoring.

Track Zydus Lifesciences Share Price on Univest

Use Zydus Lifesciences Ltd. (ZYDUSLIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track Zydus Lifesciences Share Price on Univest for live price updates, valuation ratios, financial results, market capitalisation, 52-week levels and peer context. The platform also helps follow Zydus Lifesciences Share Price Today alongside Zydus Lifesciences Company News, Zydus Lifesciences Stock Performance and Zydus Lifesciences Fundamental Analysis in one place. For investors checking Zydus Lifesciences Share News or Zydus Lifesciences Share Price Live, Univest offers a concise market view with the latest figures and sector context.